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rbB1 receptors situated on cellular ﬁlopodia un-
dergo systematic retrograde transport after binding
of the epidermal growth factor (EGF) and activation
of the receptor tyrosine kinase. Speciﬁc inhibitors of the
erbB1 receptor tyrosine kinase as well as cytochalasin D,
a disruptor of the actin cytoskeleton, abolish transport but
not free diffusion of the receptor–ligand complex. Diffu-
sion constants and transport rates were determined with
single molecule sensitivity by tracking receptors labeled
with EGF conjugated to ﬂuorescent quantum dots. Retro-
E
 
grade transport precedes receptor endocytosis, which
occurs at the base of the ﬁlopodia. Initiation of transport
requires the interaction and concerted activation of at
least two liganded receptors and proceeds at a constant
rate mediated by association with actin. These ﬁndings
suggest a mechanism by which ﬁlopodia detect the pres-
ence and concentration of effector molecules far from the
cell body and mediate cellular responses via directed
transport of activated receptors.
 
Introduction
 
ErbB1 (EGFR, HER2), the prototype of Class I transmembrane
receptor tyrosine kinases, is the receptor for epidermal growth
factor (Jorissen et al., 2003). Activation induced by the extracel-
lular binding of EGF triggers several signaling cascades respon-
sible for cellular motility, DNA replication, and cell division.
Despite the recent crystallographic elucidation of the complex of
the erbB1 ectodomain with EGF (Garrett et al., 2002; Ogiso et
al., 2002) and intensive cellular and biochemical investigations
of the receptor over the past 20 yr, fundamental questions remain
concerning the structural determinants of receptor affinity, asso-
ciation states, internalization dynamics, and intracellular traffick-
ing and signaling (Yarden and Sliwkowski, 2001; Schlessinger,
2002; Mattoon et al., 2004). These issues are of biomedical im-
portance given that the overexpression and mutation of erbB1
and the three other members of the erbB family are linked to
many types of cancer (for review see Marmor et al., 2004).
We recently demonstrated that complexes of streptavidin-
conjugated quantum dots (QDs) with biotinylated EGF (EGF-
QD) are biochemically competent ligands for erbB1 and that
their unique fluorescence properties (brightness, selectivity,
and photostability) meet the requirements for prolonged in vivo
imaging (Lidke et al., 2004). We detected a previously unre-
ported retrograde transport of activated erbB1 receptors on cel-
lular filopodia and postulated that it might be linked directly or
indirectly to the cytoskeleton.
The cytoskeleton is composed of dynamic networks of
polymerized actin and tubulin and numerous associated pro-
teins that facilitate the trafficking of proteins and organelles in-
volved in cell motility, endocytosis, and signaling. Filopodia
are elongated, thin cellular processes with a core of actin bun-
dles (Small et al., 2002). Their constituent actin filaments have
pointed ends oriented toward the interior of the cell and un-
dergo growth and exchange by the concerted addition of mono-
mers to the distal plus ends and depolymerization from the mi-
nus ends, a process denoted as treadmilling. Concurrently,
F-actin is actively transported toward the cell interior by motor
proteins (Mallavarapu and Mitchison, 1999). These processes
result in a net retrograde flow of F-actin. Passive association
with actin subunits of the filaments results in the retrograde
progression of associated macromolecules and their cargo to-
ward the cell body, whereas molecular motors are capable of
actively transporting along actin in either direction (Small et
al., 2002; Loomis et al., 2003).
In the present study, we examined in detail the binding of
ligand to the erbB1 receptor and its subsequent retrograde
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transport, including the effects of agents that perturb receptor
activation and/or the cytoskeleton. We show by quantitative,
spectrally resolved, real-time imaging with single molecule
(QD) sensitivity that (a) specific inhibitors of the erbB1 kinase
as well as cytochalasin D, a disruptor of F-actin, abrogate retro-
grade transport, whereas the binding of nocodazole, an inhibi-
tor of microtubulin dynamics, has no effect; (b) the initiation of
retrograde transport requires the cooperative interaction of at
least two activated receptors and proceeds at a constant rate
similar to that of actin flow in the same filopodium; and (c) the
ligand–receptor complex is endocytosed only upon reaching
the lamellipodial base of the filopodia. We propose that the
filopodia serve as sensory organelles probing for the presence
and concentration of effector molecules far from the cell body.
ErbB1 receptors on the filopodia become activated when
ligand exceeds a threshold concentration, triggering transport
back to the cellular machinery required for signal transduction.
 
Results
 
Binding and activation of EGF-QD 
on filopodia
 
Addition of the EGF-QD ligand to epidermal cells led to rapid
binding to erbB1 receptors on the cell surface, including filopo-
dia from which they were transported toward the cell body
(Lidke et al., 2004). Activation of the receptor occurred on the
filopodia during transport as shown in Fig. 1, demonstrating a
direct correlation (Fig. 1 D) between the signals from the EGF-
QD and those for activated erbB1 (anti-erbB1 phosphoty-
rosine-1068). The signals were discrete; i.e., activation was
restricted to each EGF-QD–erbB1 locus and did not extend to
regions between them. The transport of EGF-QD–erbB1
complexes along the filopodia can be viewed in Fig. 2 A and
Video 1 (available at http://www.jcb.org/cgi/content/full/
jcb.200503140/DC1).
 
Rate of retrograde transport and the 
effects of inhibitors
 
We used quantitative microscopy to distinguish between the
processes of random diffusion and directed transport of sur-
face-bound EGF-QDs. Tracks of EGF-QD–erbB1 complexes
undergoing retrograde transport on a filopodium showed diag-
onal trajectories when viewed as x-t and y-t projections (Fig.
2 A, kymograph), indicative of a uniform rate of motion with a
Figure 1. Activation of erbB1 by binding of EGF-QD. A431 cells express-
ing endogenous erbB1 after incubation with 1 nM EGF-QD for 15 min at
4 C followed by 5 min at 37 C were fixed in 4% PFA and immunostained
with anti-activated erbB1 and Cy5 GAMIG. (A) QD signal. (B) Activated
erbB1. (C) DIC image. (D) Two-dimensional histogram showing the corre-
lation between QD signal and antibody signal. Stacks of three confocal
images at each wavelength were deconvolved. Bar, 5  m.
Figure 2. Quantitative evaluation of receptor
diffusion and retrograde transport. (A) Ret-
rograde transport of EGF-QD–erbB1s on
filopodia of living A431 cells expressing en-
dogenous  erbB1 and erbB1-eGFP. (top left)
Magnified region of the cell periphery show-
ing filopodia (green) with bound EGF-QDs
(red). Kymograph of the EGF-QD fluorescence
signals on the selected filopodium showing x
versus time (bottom left) and y versus time (top
right). The QD loci move down the filopodia
toward the cell body (located in the bottom left
corner of the image), resulting in a net move-
ment left in x and down in y. Loci that do not
transport remain in the same place over time
and show a vertical (x) and horizontal (y) line
in the projections. The turquoise line traces
one locus that transported and the green line
one that did not. Bar, 5  m. See also Video 1,
available at http://www.jcb.org/cgi/content/
full/jcb.200503140/DC1. (B) Typical MSD
plots of EGF-QD–erbB1 complexes under dif-
ferent conditions: untreated (blue), nocodazole
(red), cytochalasin D (green), and PD153035
(black). (C) Typical trajectory (left) and MSD
plot (right) for an EGF-QD–erbB1 loci undergoing diffusion on a cell treated with PD153035. The first 10 points of the MSD plot were fit to MSD   2D t
(red line). (D) Typical trajectory (left) and RMSD plot (right) for an EGF-QD–erbB1 loci undergoing directed transport on an untreated cell. The RMSD
plots were fit to RMSD   v t (red line). 
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directional velocity (in this case) 
 
v
 
 
 
 
 
 22 
 
 
 
 2 nm/s (A431 cells,
EGF-QD added at room temperature; Fig. 2 A and Video 1).
Retrograde transport was disrupted by PD153035, a spe-
cific kinase inhibitor of erbB1 (Fry et al., 1994), and by cyto-
chalasin D (Goddette and Frieden, 1986), an inhibitor of actin
polymerization, but not by nocodazole (Jordan et al., 1992),
a disruptor of microtubule dynamics (EGF-QD binding and
movement in the presence of these inhibitors can be viewed in
Videos 2 and 3, available at http://www.jcb.org/cgi/content/
full/jcb.200503140/DC1). Typical mean square displacement
(MSD) plots of QD loci in the absence or presence of the inhib-
itors are shown in Fig. 2 (B–D). The movement on cells treated
with nocodazole was similar to that on control cells. The corre-
sponding MSDs (Fig. 2 B, red and blue points, respectively)
exhibited a behavior characteristic of predominantly vectorial
transport (MSD 
 
 
 
 
 
v
 
2
 
 
 
t
 
2
 
, where 
 
 
 
t
 
 is the time interval).
Exposure of cells to cytochalasin D or PD153035 did not
inhibit EGF-QD binding, but the ensuing movement of the
complexes displayed a constrained diffusional component as
evidenced by a plateau in the MSD versus 
 
 
 
t
 
 plots (Fig. 2 B,
green and black points, respectively); i.e., retrograde transport
was blocked. The size of the restricted diffusion area was found
to be 0.15–0.3 
 
 
 
m
 
2
 
. In Fig. 2 (C and D), typical traces of EGF-
QD–erbB1 complexes undergoing diffusion or directed trans-
port, respectively, can be seen. For estimating the transport ve-
locities, the root MSDs (RMSDs) were used (RMSD 
 
 
 
 
 
v
 
 
 
t
 
;
Fig. 2 D). We conclude that at least two conditions must be ful-
filled to promote retrograde movement: (a) the erbB1 receptor
tyrosine kinase must be activated and (b) the central filopodial
actin bundle must remain intact.
Retrograde-directed transport of EGF-activated erbB1 on
filopodia was not unique to A431 cells expressing high levels
of receptors but also occurred on HeLa cells with only 60,000
endogenous erbB1 receptors or on MCF7 cells transfected with
erbB1 (velocity data for these cell types are included in Table I).
Transport on these cells was also inhibited by PD153035 and
cytochalasin D.
Simultaneous tracking of the activated erbB1 receptor
with EGF-QD and measurement of actin flow in filopodia of
HeLa cells were performed by photobleaching the expressed
eGFP-actin at the loci of transporting QDs (Fig. 3). The dis-
placement of photobleached eGFP-actin segments paralleled
that of transporting QDs, suggesting that transport involves
coupling to the actin filament.
Table I summarizes the values for transport velocities and
diffusion coefficients derived from MSD plots with and with-
out inhibitors and for different cell types and temperatures. At
room temperature, similar transport rates of 10–20 nm/s were
obtained in untreated cells and cells treated with nocodazole.
A significant change in velocity was not observed at higher
temperatures. The velocity of retrograde transport was similar
in all cell types despite the differences in receptor density, indi-
cating the existence of a conserved mechanism.
The diffusion constants determined from PD153035- and
cytochalasin-treated cells for erbB1 of 3–4 
 
 
 
 10 
 
 
 
11
 
 cm
 
2
 
/s are
lower than the values in the literature of 1–5 
 
 
 
 10
 
 
 
10
 
 cm
 
2
 
/s de-
termined from FRAP (Zidovetzki et al., 1981; Hillman and
Schlessinger, 1982) or single particle tracking (Kusumi et al.,
1993). The erbB1 receptors situated on the filopodia do not
constitute a unique fraction of receptors in that they exchange
freely with molecules on the main cell body, as can be ob-
served in Fig. 4 for data from a FRAP experiment. Diffusion
coefficients were determined on the cell body for unliganded
(6 
 
 
 
 10
 
 
 
10
 
 
 
 
 
 3 
 
 
 
 10
 
 
 
10
 
 cm
 
2
 
/s; 
 
n
 
 
 
 
 
 12) and liganded (4 
 
 
 
10
 
 
 
10
 
 
 
 
 
 1 
 
 
 
 10
 
 
 
10
 
 cm
 
2
 
/s; 
 
n
 
 
 
 
 
 11) erbB1-eGFP expressed in
A431 cells from such data. The values for the liganded receptor
derived from both the eGFP and fluorescent EGF (Alexa 546)
signals were the same.
 
Transport requires dimerization of 
erbB1–ligand complexes
 
In our previous study, we demonstrated that monovalent EGF-
QD is capable of binding to and inducing the internalization of
erbB1 (Lidke et al., 2004). However, these binding experiments
were conducted at ligand concentrations that were not limiting
 
Table I. 
 
Parameters derived from MSD trajectories
Cell type Inhibitor Temp.
 
D 
 
 
 
 
 
10
 
 
 
11
 
vn
 
 
 
Cc m
 
2
 
/s nm/s
 
A431 - 23 18 
 
 
 
 10 19
A431-erbB3-mCit - 23 16 
 
 
 
 87
A431 Cytochalasin D 23 4.2 
 
 
 
 32 4
A431 Nocodazole 23 10 
 
 
 
 81 8
A431 PD153035 23 3.8 
 
 
 
 31 3
A431 - 37 23 
 
 
 
 20 7
HeLa - 37 16 
 
 
 
 24
HeLa - 30 26 
 
 
 
 14 19
MCF7-erbB1-
 
 
 
989–994 - 30 27 
 
 
 
 19 8
 
Values reported as weighted mean 
 
 
 
 SD. 
 
D
 
, diffusion constant; 
 
v
 
, velocity;
 
n
 
, number of loci tracked.
Figure 3. Simultaneous tracking of GFP-actin
and EGF-QD–erbB1. Selected frames from time
series of EGF-QD–erbB1 (red) undergoing
transport on the filopodia of HeLa cells express-
ing GFP-actin (green). After bleaching of GFP-
actin (in yellow box), the QDs (arrowheads)
are transported to the cell body (top left corner)
at the same rate as the unbleached GFP-actin.
(right) DIC image of filopodia. Images are sin-
gle 1- m confocal sections, Gaussian filtered,
and contrast enhanced. Bar, 5  m. 
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(2 nM). Due to the brightness and photostability of QDs, single
molecules can be tracked for extended periods of time (Dahan
et al., 2003). Direct proof that a single complex of EGF-QD
with erbB1 is not transport competent was obtained by carrying
out binding at very low concentrations of EGF-QD (5 pM for a
short time), such that only one isolated EGF-QD–erbB1 com-
plex formed on a filopodium. These EGF-QD loci exhibited
only diffusive behavior. At 5 min, 100 pM of unlabeled EGF
was added, resulting in the rapid initiation of the transport of the
EGF-QD–erbB1 complex toward the cell body (Fig. 5, A and
B). The inability of isolated (monomeric), ligand-bound, but
presumably nonactivated, receptors to engage in retrograde
transport is an important new finding of this study.
We often observed the merging of two EGF-QD loci and
a concomitant increase in fluorescence intensity when EGF-
QD motion changed from diffusion to directed transport (Fig. 5,
C and D; and Video 4, available at http://www.jcb.org/cgi/content/
full/jcb.200503140/DC1). This result implied a requirement
for dimerization or higher order oligomerization of activated
erbB1 before the onset of transport, which characteristically
commenced following a short lag (
 
 
 
10 s) after the increase in
intensity. That dimerization was sufficient was corroborated
by an alternative approach in which we mixed two different
colors of EGF-QD ligands at low concentrations and acquired
a time series of images using a charge coupled device camera
with which single QDs of both types were readily detectable.
After merging of the two colors and a lag time of a few sec-
onds, diffusion of the individual particles changed to transport
of the joint nanoparticles (Fig. 5, E and F; and Video 5, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200503140/
DC1). These data and the inhibition of retrograde transport by
erbB1-specific kinase inhibitors (Fig. 2, B and C; and Video 2)
demonstrate that the minimum requirement for activation and
subsequent transport is the formation of a 2:2 EGF–erbB1
dimer complex, consistent with the hypothesis that activation
of erbB1 requires the binding of two ligands to a receptor ho-
modimer (Lemmon et al., 1997; Schlessinger, 2002). However,
at the EGF-QD concentrations between 100 and 200 pM used
in most experiments, we observed a distribution of signal inten-
sities compatible with the transport as a cohort of either closely
packed dimers or higher order oligomers. The latter were dem-
onstrated in previous studies based on rotational diffusion mea-
surements with triplet probes (Zidovetzki et al., 1981).
Although EGF-QDs bound to receptors in the presence of
the erbB1 kinase inhibitor, the affinity for the ligand was re-
duced, as evidenced by the loss of bound QDs upon dilution.
This observation is compatible with the increased dissociation
rates reported by Mattoon et al. (2004) for EGF bound to cells
expressing mutant receptors that are dimerization incompetent
and fail to autophosphorylate.
 
Filopodial retrograde transport of erbB1 
occurs before endocytosis
 
To determine whether the receptor complexes were internalized
(endocytosed) before, during, or after retrograde transport, we
examined the accessibility of the EGF-QD–erbB1 complex on
A431 cells to the external medium using two strategies. The
first was based on the known reversibility of receptor-bound
EGF upon exposure to acidic conditions (Haigler et al., 1980).
Washing with 10 mM HCl in 150 mM NaCl caused immediate
Figure 4. FRAP of unliganded erbB1-eGFP on filopodia and cell membrane.
(A) Frame before bleaching; (B) first frame after bleaching; (C) frame 10 s
into the recovery curve. Arrows indicate the photobleached regions.
Bar, 5  m.
Figure 5. Oligomerization is required for retrograde transport. (A) Selected
frames of an A431-erbB1-eGFP cell (green) from a time series after bind-
ing 5 pM EGF-QD (red) followed by addition of free EGF (50 ng/ml) at
300 s. Bar, 5  m. Images are contrast enhanced. (B) Trajectory of the in-
dicated monomer EGF-QD–erbB1 complex (A, arrowhead) on a filopo-
dium that exhibits random diffusional movement (black) until the addition
of unlabeled EGF (green box), after which the complex commences active
retrograde transport (red). (C) Trajectory of EGF-QD–erbB1 complex on a
filopodium of an A431 cell. The locus initially undergoes diffusion (black)
before active transport begins (red). (D) Plot of intensity versus time of the
locus in the trajectory in C. See also Video 4, available at http://
www.jcb.org/cgi/content/full/jcb.200503140/DC1. (E) Time series of
two different colored EGF-QD–erbB1 complexes (EGF-QD525 tracked by
green arrowhead and EGF-QD605 tracked by red arrowhead) on a single
filopodium of an A431 cell showing merging (yellow arrowhead) followed
by transport to the cell body (bottom left). See also Video 5, available at
http://www.jcb.org/cgi/content/full/jcb.200503140/DC1. Bar, 5  m.
Images are contrast enhanced. (F) Trajectory of the two loci in D before
and after dimerization. 
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release of the QDs from the filopodia (Fig. S2, available at http:
//www.jcb.org/cgi/content/full/jcb.200503140/DC1). The sec-
ond technique avoided the adverse condition of extreme pH by
exploiting the property of QDs as donors for fluorescence reso-
nance energy transfer (FRET; Clapp et al., 2004; Grecco et al.,
2004). At the EGF/QD loading ratios used in our experiments,
the QDs retained free biotin binding sites. Thus, the addition of
a membrane-impermeable, biotinylated fluorophore with an ab-
sorption peak corresponding to the QD emission band should
result in quenching by FRET only of QDs accessible to the ex-
tracellular buffer; i.e., not yet internalized (Fig. 6 B). In these
studies, two combinations of donor-acceptor pairs were used:
EGF-QD525 with biocytin-Alexa546 and EGF-QD565 with
biocytin-Alexa594. In both cases, addition of the potential ac-
ceptor to the medium led to an immediate (within 1 s) and sub-
stantial (50–60%) quenching of QDs bound to or transporting
on the filopodia (Fig. 6 A). The amount of quenching observed
was consistent with control experiments in which the acceptor
was added to QDs fixed to a coverslip or in a cuvette. In con-
trast, QDs already internalized at the base of the filopodia or lo-
cated elsewhere within the cell were unaffected. The FRET ef-
fect was confirmed by observing emission of the Alexa546
bound to the external EGF-QD525–erbB1 as seen in Fig. 6 C in
which the QDs on the filopodium (arrows) and the cell surface
(asterisk) are seen in yellow and internalized QDs in green.
We determined that clathrin, a component of the clathrin-
coated pits presumed to be the entry sites for endocytosis, is re-
stricted to the cell body by immunostaining (Fig. S2). This re-
sult was consistent with earlier studies of Semliki Forest Virus
uptake (Helenius et al., 1980) in which clathrin was shown to
be absent on filopodia and microvilli but clustered at the base
of these structures (Hasson and Mooseker, 1995; Small et al.,
2002), the site of viral entry.
 
Is the interaction of erbB1 with filopodial 
actin filaments direct or indirect?
 
ErbB1 binds actin in vitro and the EGF high-affinity binding
class of receptors are immunoprecipitated from cell extracts
with antibodies to the actin cytoskeleton (den Hartigh et al.,
1992), raising the possibility that the receptor binds directly to
the actin bundle to initiate retrograde transport. However, in a
more recent study, Stoorvogel et al. (2004) reported that muta-
tion of the actin binding domain of erbB1 does not inhibit re-
ceptor uptake but rather abrogates downstream degradation.
MCF7 cells were transfected with this mutant 
 
 
 
989–994 erbB1
or wild-type erbB1, and EGF-QD binding and internalization
were compared. Retrograde transport occurred equally in all
transfected cells, demonstrating that erbB1 was not bound di-
rectly to F-actin filaments via this sequence motif.
 
Discussion
 
We have demonstrated at the single molecule level that a dimer
of EGF-liganded and activated erbB1 receptors is the minimal
species competent for transport along the filopodium toward
the cell body (Fig. 5). The transport velocities of the erbB1-
activated complex (Table I) were similar in all the cell types
expressing either endogenous or transfected erbB1, indepen-
dent of receptor expression on the cell surface, which ranged
from 6 
 
 
 
 10
 
4
 
 to 2 
 
 
 
 10
 
6
 
 receptors/cell. Thus, the mechanism
appears to be widespread and conserved. There was no signifi-
cant difference in the transport rates over a temperature range
of 23–37
 
 
 
C. Fewer loci were measured at the higher tempera-
tures (Table I) due to the rapid movements of filopodia, making
tracking of individual EGF-QD–erbB1 complexes difficult.
Although the actin cytoskeleton is required for transport,
erbB1 does not bind directly to the actin filament through the
reported actin-binding motif (amino acids 989–994 in the se-
quence). Our measured transport velocities on the filopodia fell
within the range of values (up to 55 nm/s) reported for actin
retrograde flow in vivo (Mallavarapu and Mitchison, 1999;
Pollard and Borisy, 2003). In addition, we observed the same
transport rate for EGF-QD–erbB1 and filopodial actin on Hela
cells expressing an eGFP-actin. Although individual rates on
different filopodia varied, the rates of multiple QD loci tracked
on a given filopodium were the same. Values for actin poly-
Figure 6. EGF-QD–erbB1s undergo retro-
grade transport before endocytosis. (A) Two
images selected from a time series just before
(left) and after (right) addition of biocytin-Alexa
594 (biotA594) to EGF-QDs undergoing ret-
rograde transport on the filopodia of A431
cells. (right) Relative fluorescence intensity
over time of the EGF-QD in the yellow box
undergoing transport, demonstrating strong
quenching. Bar, 10  m. (B) Cartoon depict-
ing the experiment: at the loading ratio of
EGF/QD used, there are still free sites on the
streptavidin conjugate layer available for bi-
otin-acceptor (pink), the binding of which re-
sults in FRET-induced quenching of the QD
donor fluorescence and concomitant sensi-
tized emission of the acceptor fluorescence.
(C) Sensitized emission localizes the sites of
internalization to the base of the filopodia.
(left) EGF-QD525–erbB1 complexes (green)
in the cell membrane being transported on the filopodia (arrows). (right) Upon addition of biotA546, the QD signal is quenched and the sensitized
emission of the acceptor (red) can be seen on the filopodial loci and the cell surface (*), whereas the complexes already internalized remain green.
Images are maximum intensity projections of two 1.0- m optical sections, Gaussian filtered, and contrast enhanced. Bar, 10  m. 
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merization are known to vary widely due to the action of auxil-
iary proteins, metabolite and energy sources, and cell type. The
apparent correlation of the actin flow rate and erbB1 retrograde
transport suggests that transport can occur without a motor pro-
tein such as myosin VI that transports in a retrograde direction
toward the minus ends of actin filaments (Buss et al., 2004).
Diffusion constants in the range of 1–5 
 
 
 
 10
 
 
 
10
 
 cm
 
2
 
/s
were determined by FRAP and particle tracking measurements
of liganded erbB1 on A431 cells, in which a large immobile
fraction was also observed (Zidovetzki et al., 1981; Hillman
and Schlessinger, 1982; Kusumi et al., 1993). We measured
similar diffusion rates by FRAP for both the unliganded and
liganded receptor using an erbB1-eGFP fusion protein stably
expressed in A431 cells (Fig. 4). FCS measurements of erbB1-
eGFP have yielded diffusion constants larger by an order
of magnitude than those derived from FRAP (Brock et al.,
1999b), probably due to the faster acquisition times and more
restricted measurement volumes in FCS. The diffusion con-
stants from EGF-QD tracking reported here are about half
those determined by FRAP measurements. These differences
may be due to the fact that our measurements of single mole-
cules and small aggregates were acquired with a relatively long
integration time and low acquisition frequency (200 ms at 1-s
intervals), conditions that would obscure fast diffusion pro-
cesses as shown by Murase et al. (2004). The size of the re-
stricted diffusion area (0.15–0.3 
 
 
 
m
 
2
 
) derived from the MSD
plots was similar to that obtained by Kusumi et al. (1993) and
implies that the receptor is organized in microdomains (Nagy
et al., 2002) in variable states of association with the underly-
ing cytoskeleton (Van Belzen et al., 1990; Yamabhai and
Anderson, 2002). At the low temporal resolution of our mea-
surements, the data may represent the rate of escape from such
domains as well as intrinsic translational diffusion.
The discrete nature of the activation restricted to loci with
bound ligand (Fig. 1) supports the thesis that the erbB1 recep-
tor provides a very sensitive measure of the local ligand con-
centration. There have been reports of lateral signal propaga-
tion from activated erbB1 to unliganded molecules (Verveer et
al., 2000). We have not observed such a phenomenon upon lo-
calized ligand presentation using EGF- or Herceptin-coupled
magnetic microspheres to cells with receptor density varying
between 6 
 
 
 
 10 
 
4
 
 and 2 
 
 
 
 10
 
6
 
 (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200503140/DC1; Brock and
Jovin, 2001, 2003; Friedländer et al., 2005). Extensive propa-
gation of activation between unliganded erbB1 molecules
would also not result in the distinct diffusion and transport be-
havior documented in this study.
Our present view of directed transport along filopodia is
depicted schematically in Fig. 7, indicating the conformational
states and protein modifications of erbB1 that promote interac-
tion with the F-actin filament and subsequent transport. The
EGF receptor is present in either monomeric or oligomerized
(not depicted) forms. Binding of EGF or EGF-QD (Fig. 7,
green and red objects) leads to conformational rearrangements
in ectodomain II (including extension of the dimerization loop;
Garrett et al., 2002; Ogiso et al., 2002) and other domains (Fig.
7, black cytoplasmic region), potentiating the stabilization of an
“active dimer” competent for auto- and transphosphorylation.
The phosphoprotein (-P) interaction may be direct or mediated
internally by adaptor proteins (Fig. 7, blue rectangles) leading
to a physical linkage of the receptor complex to F-actin fila-
ments (Fig. 7, black lines) and a shift from restricted diffusion
(Fig. 7, pair of opposed arrows) to directed retrograde transport.
The net velocity is given by the combination of the actin flow
rate and motion of the adaptor link relative to the underlying ac-
tin filaments. Uptake into the cell body (not depicted) occurs at
the base of the filopodium, where clathrin-coated pits and other
components of the endocytic machinery are first available. As
yet unresolved features of the retrograde transport mechanism
are the identity of the adaptor proteins and/or receptor sequences,
the locus and nature of cooperative interactions between acti-
vated receptors and the transport machinery, as well as loading
and energetic considerations.
 
Biological roles of filopodial retrograde 
transport
 
This study indicates that a primary role for filopodia may be to
serve as a sensory system for the cell by which they assist in
regulating signal transduction pathways through transport of
receptors once a given threshold of ligand binding is attained. It
seems highly likely that filopodial retrograde transport is a gen-
eral mechanism used by a wide range of cells, depending on the
exact tissue and physiological context. Wound healing and
embryonic development are obvious examples. Zieske et al.
(2000) demonstrated in vivo in rat corneas that EGF, TGF
 
 ,
heparin-binding EGF, and amphiregulin, which are all ligands
of erbB1, are rapidly up-regulated in epithelial cells at the site
of wounds. These cytokines stimulated erbB1 in neighboring
cells and caused cell migration into the wound, whereas inhi-
bition of the erbB1 kinase activity could be shown to inhibit
migration. We have observed that vectorial application of
EGF-QDs results in rapid formation of lamellipodia extending
between the filopodia and cell movement in the direction of the
gradient. Salas-Vidal and Lomeli (2004) proposed that filopo-
dia and microvilli serve to regulate communication between
the inner cell mass and the trophoectoderm in the mouse blas-
tocyst. They demonstrated that growth factor and regulatory
receptors, FGFR and erbB3, are distinctly and differentially
enriched on these organelles dependent on the cell type. Other
Figure 7. Schematic depiction of filopodial retrograde transport of
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studies have documented the expression of all members of the
erbB family as well as their ligands in the blastocyst in which
orchestrated development requires that specific patterns of mi-
gration and differentiation be established and regulated (Paria
and Dey, 1990; Wang et al., 2000).
Activation of tyrosine kinase membrane receptors re-
quires dimerization mediated either through shared ligand
binding or by ligand-induced increased affinity (as is the case
for the erbB family; Yarden and Ullrich, 1988), and thereby
provides a means for coupling ligand and receptor density to
the regulation of downstream signaling. The discovery of retro-
grade transport of activated receptors on filopodia introduces a
new, key feature in this regulatory mechanism.
Materials and methods
Reagents
All reagents were of analytical grade. Biotin-EGF, EGF, biocytin-Alexa594,
and biocytin-Alexa546 were purchased from Molecular Probes. Qdot
Streptavidin conjugates were obtained from Quantum Dot Corporation.
PD153035, nocodazole, and cytochalasin D were purchased from Cal-
biochem. mAb CON.1 against clathrin light chain was purchased from
Dianova. Antiphosphotyrosine 1068 (active erbB1) antibody was pur-
chased from Cell Signaling Technologies. Live cell labeling was performed
in Tyrode’s buffer with 20 mM glucose and 0.1% BSA.
Plasmids and cell lines
ErbB1-eGFP expression plasmid was generated as described previously
(Brock et al., 1999a) and erbB1 lacking six amino acids, the actin consen-
sus binding sequence  989–994, was the kind gift of P. van Bergen en
Henegouwen (Universiteit Utrecht, Utrecht, Netherlands). Transient trans-
fections of HeLa, MCF7, or human adenocarcinoma A431 cells were per-
formed with Lipofectamine 2000 (Invitrogen) or Effectene (QIAGEN).
Some experiments were performed with stably transfected A431 or CHO
cell lines expressing erbB1-eGFP. A commercial eGFP-actin plasmid (Invi-
trogen) was used to make a stably transfected HeLa cell line.
EGF and QD labeling of cells
EGF-QD ligand was formed by incubation of biotin-EGF (Molecular
Probes) with 20 nM QDs at 4 C with mixing for  30 min in PBS. Most ex-
periments were performed with a 6:1 or 3:1 molar ratio of biotin-EGF/
QD. In the case of the low occupancy binding experiments, ratios of 3:1
or 1:1 were preformed and purified by size exclusion spin columns (P30;
Bio-Rad Laboratories) to exclude free EGF molecules. Cells were grown in
8-well Lab-Tek chambers (Nunc) and imaged in Tyrode’s buffer containing
glucose and BSA. EGF-QD was added to cells at QD concentrations of 5
to 200 pM. For the two-color experiment, 90 nM EGF-QD525 and 30 nM
EGF-QD605 were added simultaneously.
Cell treatments
Cells were typically starved (0.1% FCS) overnight. Cells were treated with
inhibitors before measurement as follows: 15  M nocodazole for 2 h at
37 C, 4  M cytochalasin D for 30 min at 37 C, or 1  M 153035 for 2 h
at 37 C. Cells were maintained in the drugs during retrograde transport
measurements.
Microscopy
Wide field detection of retrograde transport was recorded on a charge cou-
pled device camera (model C4742-95; Hamamatsu) attached to a micro-
scope (model Axiovert S100; Carl Zeiss MicroImaging, Inc.) with a 63 
1.4 NA oil immersion objective. Images were taken at 1-s intervals with 0.2-s
integration times. QDs were excited at 436 nm with a bandpass filter and
appropriate QD (20 nm) emission filters (Chroma Technology). Confocal la-
ser scanning microscopy was performed with an LSM 510META (Carl Zeiss
MicroImaging, Inc.) using a 63  1.2 NA water or 63  1.4 NA oil immer-
sion objective with appropriate excitation and emission settings. Generally,
three image planes at 0.5- m steps were taken at 3-s intervals for all mea-
surements. Deconvolution (as in Fig. 1) was performed using Huygens im-
age processing software (Scientific Volume Imaging).
FRAP. Photobleaching data were acquired with an LSM 510META
using a 63  1.4 NA oil immersion objective. A431 cells expressing
erbB1-eGFP in the presence or absence of EGF-StreptavidinAlexa546
were imaged at low power (400–800 ms/image) with excitation at 488
and 532 nm. Photobleaching in a region of interest (2.2- m-diam circle)
was achieved by increasing the laser to full power. In the case where EGF-
StreptavidinAlexa546 was added to the cells, the eGFP and Alexa546
were simultaneously imaged and bleached. Similarly, stably transfected
HeLa cells expressing eGFP-actin were photobleached.
Two-color time series. QDs with different emission wavelengths
were detected simultaneously using a microscope (model Axiovert S100)
with the addition of an image splitter (either the Cairn Research Optosplit
or a unit designed by R. Pick, Max Planck Institute for Biophysical Chemis-
try, Goettingen, Germany) containing appropriate QD (20 nm) bandpass
emission filters in each channel in front of the ORCA-ER charge coupled
device camera (Hamamatsu).
Data analysis
MSD calculations. QD loci were tracked over time using “View5D,” an Im-
age J (National Institutes of Health) plug-in developed by R. Heintzmann
(King’s College, London, England) that calculates the center of intensity in
a region around the maximum at each time step, or similar routines written
in Matlab (The MathWorks, Inc.). For diffusive behavior, the linear region
of the MSD curves (first 10 points) was fit to either equation MSD   2D t
for PD153035-treated cells (the factor of two results from the one-dimen-
sional geometry of the filopodia) or MSD   4D t for cytochalasin-treated
cells (the factor of four results from the two-dimensional geometry of wider
filopodia induced by cytochalasin D), where D is the diffusion constant
and  t is the time interval (Kucik et al., 1989). D was calculated as the
mean weighted by SD of the fit for each trace. The size of the restricted
diffusion area was determined from the plateau in the MSD versus  t
plots. In the case of spots exhibiting a transition from the diffusion to the
transport mode, only the active transport part of the trajectory was evalu-
ated using the equation RMSD   v t, where v is the velocity of active
transport (Kucik et al., 1989). This transition was found by visual inspec-
tion of the tracks in a time projection.
FRAP. Images were background subtracted and corrected for pho-
tobleaching during image acquisition. The post-bleach curves were fit to
obtain the recovery half-time. The half-time and circular geometry of the
bleach region were used to calculate the diffusion coefficient, D, as de-
scribed in Axelrod et al. (1976).
Two-color tracking. The two different color channels acquired on
the image splitter were registered using a calibration brightfield image
taken at the beginning of the experiment. The QD loci were tracked sepa-
rately for the different channels. The image processing was performed
with DIPimage (Delft University of Technology).
Online supplemental material
Videos 1, 4, and 5 are QuickTime movies showing the retrograde trans-
port of EGF-QD–erbB1 complexes as described in Figs. 2 A, 5 C, and 5
E, respectively. Videos 2 and 3 are QuickTime movies demonstrating the
effects of Nocodazole and cytochalasin D, respectively, on retrograde
transport. Fig. S1 shows the EGF-QDs are removed from the filopodia
upon exposure to acid. Fig. S2 shows that clathrin is not present on the
filopodia. Fig. S3 demonstrates the localized activation of erbB1 around
EGF-labeled magnetic beads. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200503140/DC1.
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